Diclofenac epolamine

This classification denotes a cyclooxygenase inhibitor C14H11Cl2NO2.C6H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X5F8EKL9ZG, chemically known as benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, compd. with 1-pyrrolidineethanol (1:1), but more generally known as diclofenac epolamine, which bears US NIH Compound Identifier 114753. European Medicines Agency schedules Diclofenac epolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20558. Most nations, for tariff and trade purposes, schedule diclofenac epolamine under HS 29224995 and SITC 51465. As of Q4 2014, DICLOFENAC EPOLAMINE remains US FDA's Preferred Term for this commodity. Diclofenac epolamine bears US NLM identifiers UMLS ID C0082274 and NCI Concept Code C77355. SMILES: C1CCC(C(C1)CC(=O)O)NC2C(CCCC2CL)CL.C1CCN(C1)CCO.